Lexology December 4, 2025
Private equity’s footprint in health care has expanded rapidly over the past decade, and in response states have begun to retool long‑standing doctrines and create new guardrails that target ownership, control, and transparency. The result is an emerging patchwork of laws and review processes that remake the corporate practice of medicine landscape, constrain common “friendly PC” structures, and require far more visibility into transactions involving private equity, hedge funds, real estate investment trusts (REITs), and management services organizations (MSOs).
What’s Driving State Action
Pushed by rising acquisition volumes and consolidation in local markets, lawmakers and attorneys general have raised concerns about affordability, continuity of care, and clinical autonomy. Physicians, now employees, report incentives to increase throughput and reduced latitude in...







